BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 32962735)

  • 1. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
    Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation.
    Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E
    Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial.
    Witters P; Andersson H; Jaeken J; Tseng L; van Karnebeek CDM; Lefeber DJ; Cassiman D; Morava E
    Orphanet J Rare Dis; 2021 Mar; 16(1):138. PubMed ID: 33743737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models.
    Radenkovic S; Budhraja R; Klein-Gunnewiek T; King AT; Bhatia TN; Ligezka AN; Driesen K; Shah R; Ghesquière B; Pandey A; Kasri NN; Sloan SA; Morava E; Kozicz T
    Cell Rep; 2024 Mar; 43(3):113883. PubMed ID: 38430517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation recovers hepatic N-glycosylation with persistent IgG glycosylation abnormalities: Three-year follow-up in a patient with phosphomannomutase-2-congenital disorder of glycosylation.
    Tahata S; Weckwerth J; Ligezka A; He M; Lee HE; Heimbach J; Ibrahim SH; Kozicz T; Furuya K; Morava E
    Mol Genet Metab; 2023 Apr; 138(4):107559. PubMed ID: 36965289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG.
    Gallego D; Serrano M; Cordoba-Caballero J; Gámez A; Seoane P; Perkins JR; Ranea JAG; Pérez B
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167163. PubMed ID: 38599261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.
    Garapati K; Budhraja R; Saraswat M; Kim J; Joshi N; Sachdeva GS; Jain A; Ligezka AN; Radenkovic S; Ramarajan MG; Udainiya S; Raymond K; He M; Lam C; Larson A; Edmondson AC; Sarafoglou K; Larson NB; Freeze HH; Schultz MJ; Kozicz T; Morava E; Pandey A
    JCI Insight; 2024 Apr; 9(7):. PubMed ID: 38587076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-mannose as a new therapy for fucokinase deficiency-related congenital disorder of glycosylation (FCSK-CDG).
    Starosta RT; Lee AJ; Toolan ER; He M; Wongkittichote P; Daniel EJP; Radenkovic S; Budhraja R; Pandey A; Sharma J; Morava E; Nguyen H; Dickson PI
    Mol Genet Metab; 2024 Jun; 142(2):108488. PubMed ID: 38735264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMM2-CDG caused by uniparental disomy: Case report and literature review.
    Vaes L; Tiller GE; Pérez B; Boyer SW; Berry SA; Sarafoglou K; Morava E
    JIMD Rep; 2020 Jul; 54(1):16-21. PubMed ID: 32685345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.
    Pascoal C; Francisco R; Mexia P; Pereira BL; Granjo P; Coelho H; Barbosa M; Dos Reis Ferreira V; Videira PA
    Front Immunol; 2024; 15():1350101. PubMed ID: 38550576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG).
    Kapusta L; Zucker N; Frenckel G; Medalion B; Ben Gal T; Birk E; Mandel H; Nasser N; Morgenstern S; Zuckermann A; Lefeber DJ; de Brouwer A; Wevers RA; Lorber A; Morava E
    Heart Fail Rev; 2013 Mar; 18(2):187-96. PubMed ID: 22327749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient glycan extension and endoplasmic reticulum stresses in ALG3-CDG.
    Daniel EJP; Edmondson AC; Argon Y; Alsharhan H; Lam C; Freeze HH; He M
    J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38597022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
    Mühlhausen C; Henneke L; Schlotawa L; Behme D; Grüneberg M; Gärtner J; Marquardt T
    JIMD Rep; 2020 Sep; 55(1):38-43. PubMed ID: 32905087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation.
    Monticelli M; Hay Mele B; Wright DM; Guerriero S; Andreotti G; Cubellis MV
    Biochimie; 2024 Mar; 222():123-131. PubMed ID: 38458414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomannomutase 2-congenital disorder of glycosylation presenting with very early onset inflammatory bowel disease.
    Comert M; Guler T; Ergani AC; Gumus M; Ozdemir EM; Artac H
    Indian J Gastroenterol; 2024 Mar; ():. PubMed ID: 38539012
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term outcome of MPI-CDG patients on D-mannose therapy.
    Girard M; Douillard C; Debray D; Lacaille F; Schiff M; Vuillaumier-Barrot S; Dupré T; Fabre M; Damaj L; Kuster A; Torre S; Mention K; McLin V; Dobbelaere D; Borgel D; Bauchard E; Seta N; Bruneel A; De Lonlay P
    J Inherit Metab Dis; 2020 Nov; 43(6):1360-1369. PubMed ID: 33098580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Fucose treatment of FUT8-CDG.
    Park JH; Reunert J; He M; Mealer RG; Noel M; Wada Y; Grüneberg M; Horváth J; Cummings RD; Schwartz O; Marquardt T
    Mol Genet Metab Rep; 2020 Dec; 25():100680. PubMed ID: 33312876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular ring anomaly in a patient with phosphomannomutase 2 deficiency: A case report and review of the literature.
    Qian Z; Van den Eynde J; Heymans S; Mertens L; Morava E
    JIMD Rep; 2020 Nov; 56(1):27-33. PubMed ID: 33204593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy.
    Noman K; Hendriksz CJ; Radcliffe G; Roncaroli F; Moreea S; Hussain A; Stepien KM
    Mol Genet Metab Rep; 2020 Dec; 25():100646. PubMed ID: 32963965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway.
    López-Gálvez R; de la Morena-Barrio ME; López-Lera A; Pathak M; Miñano A; Serrano M; Borgel D; Roldán V; Vicente V; Emsley J; Corral J
    Orphanet J Rare Dis; 2020 Oct; 15(1):280. PubMed ID: 33036649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.